Silence Therapeutics soars 125% on Merck KGaA acquisition
FROM THE WIRE · FINANCE.YAHOO.COM
Investing.com -- Silence Therapeutics shares leapt more than 125% in premarket trading Monday after the company announced it has entered into a definitive agreement to be acquired by Germany's Merck KGaA in an all-cash transaction. Still guessing which stocks will beat the…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA cash offer at a large premium anchors the stock near the acquisition value.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Merck KGaA will acquire Silence Therapeutics in an all-cash deal.
- 02The price is $20 per ADS, a 130% premium to Friday's close.
- 03The equity value is about $1.3 billion.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets